GTBP

• 

  GT Biopharma Announces $7.1 Million Convertible Debt Financing

  11:18 AM | January 23, 2018

  LOS ANGELES, January 23, 2018 /PRNewswire/ — GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris: GTBP.PA) today announced that it has entered into definitive agreements for a private placement of convertible notes and warrants for gross proceeds of $7,055,000. The company intends to use the proceeds from the financing to advance its immuno-oncology programs, which are based on the company’s proprietary Tri and Tetra-specific Natural Killer Cell Engagers (TriKEs™ and TetraKEs) and bispecific antibody-drug conjugate (ADC) platforms, neurology (CNS) pipeline progress, and for

  Read more
• William Penn Bancorp, Inc. Completes Stock Repurchase

  2:24 PM | May 29, 2015

  LEVITTOWN, Pa., May 29, 2015 /PRNewswire/ — William Penn Bancorp, Inc.  (OTC Pink: WMPN), the holding company for William Penn Bank, announced today that it had completed a  repurchase of 20,000 shares, or 2.03%, of the Company’s outstanding common stock, excluding shares held by William Penn MHC.  After the transaction, the Company has 964,305 shares of common stock outstanding, excluding shares held by William Penn MHC.  The repurchase was undertaken in an unsolicited, privately negotiated transaction with a single shareholder outside of the stock

  Read more